Pathogenic Anti-C1q Antibodies Potentiate Activation of the Classical Complement Pathway in a Subset of Lupus Nephritis Patients

被引：0
|
作者：
Chang, Edmund [1 ]
Low, Julian [2 ]
Cahir-McFarland, Ellen [2 ]
Kroon, Henk-Andre [2 ]
Andrews-Zwilling, Yaisa [2 ]
Yednock, Ted [2 ]
Mongan, Ann [2 ]
机构：
[1] Annexon Biosci, Brisbane, CA USA
[2] Annexon Biosci, South San Francisco, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0648
引用
收藏
页码：1292 / 1294
页数：3
相关论文
共 50 条
  • [41] Study of Anti-C1q Antibodies in Egyptian Systemic Lupus Erythematosus Patients
    Eldin, Reham Emad
    Marie, Mohamed A.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2022, 33 (01) : 66 - 71
  • [42] Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab
    Tsanyan, M. E.
    Torgashina, A. V.
    Aleksandrova, E. N.
    Soloviev, S. K.
    Nasonov, E. L.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (05) : 53 - 59
  • [43] Anti-C1q autoantibodies in lupus nephritis prevalence and clinical significance
    Sinico, RA
    Radice, A
    Ikehata, M
    Giammarresi, G
    Corace, C
    Arrigo, G
    Bollini, B
    Vecchi, ML
    AUTOIMMUNITY: CONCEPTS AND DIAGNOSIS AT THE CUTTING EDGE, 2005, 1050 : 193 - 200
  • [44] Erythrocyte C4d and Antibodies to Anti-C1q Are Associated with Proteinuria in Lupus Nephritis.
    Buyon, Jill P.
    Ramsey-Goldman, R.
    Furie, Richard
    Putterman, Chaim
    Kalunian, Kenneth
    Conklin, John
    O'Malley, Tyler
    Barken, Derren
    Dervieux, Thierry
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S710 - S710
  • [45] Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus
    Magro-Checa, C.
    Schaarenburg, R. A.
    Beaart, H. J. L.
    Huizinga, T. W. J.
    Steup-Beekman, G. M.
    Trouw, L. A.
    LUPUS, 2016, 25 (08) : 878 - 888
  • [46] Results of Single-Arm, Phase 1b Study of Anti-C1q Treatment (ANX009) Show That the Classical Pathway Is a Key Driver of Complement Activation and Consumption in Patients with Active Lupus Nephritis
    Dall'Era, Maria
    Lichauco, Juan
    Chen, Hsiang
    Gomez, Harold
    Tee, Michael
    Arroyo, Caroline
    Lan, Joung-Liang
    Fang, Yao-Fan
    Chang, Edmund
    Yousefpour, Noosha
    Low, Julian
    Bao, Min
    Chang, Qing
    Osterloh, Jeannette
    Mongan, Ann
    Yednock, Ted
    Artis, Dean
    Andrews-Zwilling, Yaisa
    Kroon, Henk-Andre
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4632 - 4633
  • [47] Anti-C1q autoantibodies from SLE patients activate the complement system via both the classical and the lectin pathway
    Thanei, Sophia
    Vanhecke, Dominique
    Trendelenburg, Marten
    MOLECULAR IMMUNOLOGY, 2015, 67 (01) : 187 - 187
  • [48] THE VALUE OF ANTI-C1Q ANTIBODIES IN PREDICTING THE CLINICAL-HISTOLOGICAL FEATURES OF LUPUS NEPHRITIS PATIENTS AT TIME OF KIDNEY BIOPSY
    Calatroni, Marta
    Conte, Emanuele
    Reggiani, Francesco
    de Liso, Federica
    LuisaMoroni, Gabriella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I317 - I318
  • [49] Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss
    Ohmura, Kazumasa
    Oku, Kenji
    Kitaori, Tamao
    Amengual, Olga
    Hisada, Ryo
    Kanda, Masatoshi
    Shimizu, Yuka
    Fujieda, Yuichiro
    Kato, Masaru
    Bohgaki, Toshiyuki
    Horita, Tetsuya
    Yasuda, Shinsuke
    Sugiura-Ogasawara, Mayumi
    Atsumi, Tatsuya
    CLINICAL IMMUNOLOGY, 2019, 203 : 37 - 44
  • [50] Induction of murine lupus-nephritis with an anti-C1q monoclonal antibody
    Trouw, LA
    Seelen, MA
    Groeneveld, TWL
    Duijs, JMGJ
    Bajema, I
    Prins, F
    Kishore, U
    Salant, DJ
    Verbeek, SJ
    Van Kooten, C
    Daha, MR
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 319 - 320
12345